Dennis Schrijnders

Publications
  1. Oral glucose lowering agents and cancer in type 2 diabetes mellitus: focus on sulphonylurea derivatives

    Schrijnders, D., 2019, [Groningen]: Rijksuniversiteit Groningen. 192 p.

    Research output: ThesisThesis fully internal (DIV)Academic

  2. Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: A cohort study (ZODIAC-56)

    Hendriks, S. H., Schrijnders, D., van Hateren, K. J. J., Groenier, K. H., Siesling, S., Maas, A. H. E. M., Landman, G. W. D., Bilo, H. J. G. & Kleefstra, N., Jan-2018, In : BMJ Open. 8, 1, 8 p., 018859.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49)

    Schrijnders, D., Hendriks, S. H., Kleefstra, N., Vissers, P. A. J., Johnson, J. A., de Bock, G. H., Bilo, H. J. G. & Landman, G. W. D., 25-Jan-2018, In : PLoS ONE. 13, 1, 17 p., 0190870.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Within-Sulfonylurea-Class Evaluation of Time to Intensification with Insulin (ZODIAC-43)

    Schrijnders, D., Hartog, L. C., Kleefstra, N., Groenier, K. H., Landman, G. W. D. & Bilo, H. J. G., 21-Jun-2016, In : PLoS ONE. 11, 6, 8 p., e0157668.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Addition of sulphonylurea to metformin does not relevantly change body weight: a prospective observational cohort study (ZODIAC-39)

    Schrijnders, D., Wever, R., Kleefstra, N., Houweling, S. T., van Hateren, K. J. J., de Bock, G. H., Bilo, H. J. G., Groenier, K. H. & Landman, G. W. D., Oct-2016, In : Diabetes obesity & metabolism. 18, 10, p. 973-979 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (6) »

ID: 14703142